Close Menu

NEW YORK (GenomeWeb) – German molecular diagnostics firm Curetis announced today that it has submitted its Unyvero system and Unyvero lower respiratory tract (LRT) panel for approval to the US Food and Drug Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.